NCT07773974

Brief Summary

People living with SCI may experience loss of sensation, movement and regular body function. One way to address these impairments is activity-based therapy (ABT), which includes movement-based activities that promote the muscle-brain connection below the level of injury. A technology often used during ABT is functional electrical stimulation (FES), which is an electrical stimulus applied to nerves or paralyzed muscles through sticky gel pads placed on the skin. The purpose of this multi-method pilot study is to look at the safety, interest in and acceptance of an at-home, virtual training program that combines FES with high intensity interval training (HIIT). Up to 24 individuals with SCI will be enrolled in the study. The study activities will span over 34 weeks, from pre-training tests to the 12-week follow-up tests.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
21mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

1.8 years

First QC Date

August 11, 2026

Last Update Submit

August 14, 2026

Conditions

Keywords

functional electrical stimulationhigh intensity interval traininghome-based rehabilitation

Outcome Measures

Primary Outcomes (15)

  • Enrollment rates

    Number of participants screened per month (plus reasons for exclusion) and the number of participants enrolled per month

    During enrollment

  • Adherence

    Session attendance (plus reasons for absences) and assessment attendance (plus reasons for omissions)

    From enrollment until the end of the study at 34 weeks

  • Feasibility of FES+HIIT@Home

    Number of sessions in which each participant achieves the targeted "all out" RPE (and HR for those with lower thoracic SCI)

    During the FES+HIIT@Home intervention

  • Attrition

    Number of participants who drop out of the study and the reasons for drop out

    From enrollment until the end of the study at 34 weeks

  • Safety of FES+HIIT@Home

    Number of minor and serious adverse events

    From enrollment until the end of the study at 34 weeks

  • Function for participants unable to stand

    Function will be assessed with the Function in Sitting Test (FIST-SCI) for participants unable to stand. The FIST-SCI assesses postural control during functional sitting activities. Items are rated on the amount of assistance required to accomplish each task on a 5-point scale of 0 (complete assistance - patient cannot perform the task at all) to 4 (independent - patient completely autonomous in performing the task). Scores can be summed for a total score ranging from 0 to 56.

    From enrollment to the end of the 12-week follow-up at 34 weeks

  • Function for participants able to stand

    Function will be assessed with the mini-Balance Evaluation Systems Test (mini-BESTest) for participants who are able to stand. The mini-BESTest assesses a variety of functional activities in standing and walking. The Mini BESTest is scored on a 3-level ordinal scale (0 to 2). Scores can be summed for a total score between 0 and 28.

    From enrollment until the end of the study at 34 weeks

  • Muscle Strength

    Isometric strength of the trunk, upper limb and lower limb muscles will be evaluated with manual muscle testing (MMT) and/or hand-held dynamometry. Testing positions will be standardized, following guidelines of the ISNCSCI, as appropriate, and strength scored on a 0 to 5 scale. Muscles with a MMT score of ≥4 will also be assessed with hand-held dynamometry, which is a valid assessment method that has greater sensitivity to detect changes in the strength of stronger muscles. Three peak force values will be collected per muscle group and the mean value normalized by body weight.

    From enrollment until the end of the study at 34 weeks

  • Penn Spasm Frequency Scale

    The Penn Spasm Frequency Scale is a valid and reliable self-report measure that evaluates an individual's perception of spasticity frequency (on a 5-point scale from 0 (no spasms) to 4 (spontaneous spasms occurring ≥10 times/hour)) and severity (on a 3-point scale from 1 (mild) to 3 (severe)). A spasm severity rating will not be provided if spasm frequency is 0.

    From enrollment until the end of the study at 34 weeks

  • Spinal Cord Assessment Tool for Spastic Reflexes

    The Spinal Cord Assessment Tool for Spastic Reflexes is a short clinical exam of three spastic motor behaviors in the lower limb of individuals with SCI: clonus, flexor spasms and extensor spasms. The reactions observed for each motor behavior will be rated on a 4-point ordinal scale and summed for a total score (/9).

    From enrollment until the end of the study at 34 weeks

  • Exercise Self-efficacy Scale

    Exercise self-efficacy will be assessed with the SCI Exercise Self-efficacy Scale, which assesses confidence in performing exercise. Participants will rate their confidence, on a scale from 1 (not always true) to 4 (always true), for ten statements related to carrying out regular exercise and physical activity. Reponses are summed for a total score (/40).

    From enrollment until the end of the study at 34 weeks

  • Cardiorespiratory fitness

    VO2peak (mL/kg/min), will be evaluated with a maximal graded exercise test. Breath-by-breath gas samples will be collected and averaged over 20 seconds via a calibrated metabolic cart to determine V̇O2peak.

    From enrollment until the end of the study at 34 weeks

  • Arterial stiffness

    Pulse wave velocity (PWV, m/s) will be obtained between the common carotid and common femoral arteries (cfPWV). cfPWV (m/sec) will be calculated using the equation: (0.8 × D)÷Δt, where D is the distance between measurement sites and Δt is the pulse transit time.

    From enrollment until the end of the study at 34 weeks

  • Description of the contexts that impact outcomes of FES+HIIT@Home

    To describe the contexts (e.g., virtual setting, group sessions) that impact outcomes from the perspectives of people with SCI

    After 24 sessions (or 8 weeks) of the FES+HIIT@Home intervention and at the 12-week follow-up at 34 weeks

  • Description of the mechanisms that impact outcomes of FES+HIIT@Home

    To describe the mechanisms (e.g., FES, HIIT, education) that impact outcomes from the perspectives of people with SCI

    After 24 sessions (or 8 weeks) of the FES+HIIT@Home intervention and at the 12-week follow-up at 34 weeks

Study Arms (1)

FES+HIIT@Home

EXPERIMENTAL

Functional electrical stimulation combined with high intensity interval training at home

Other: FES+HIIT@Home

Interventions

The FES+HIIT@Home intervention will be 16 weeks in duration. During the first four weeks of the FES+HIIT@Home intervention (i.e., weeks 3-6), participants and caregivers who will be assisting will receive education and hands-on training with FES and HIIT exercises. Each participant will receive a two-channel FES device to keep (i.e., Chattanooga® Continuum). During weeks 7-18, participants will complete 36 online, group-based FES+HIIT@Home sessions (i.e., three 1-hour sessions/week for 12 weeks) that are led by trainers over Microsoft Teams. Sessions will include warm-up exercises (10 minutes), three task-specific exercises (15 minutes/exercise) and cool-down exercises (5 minutes). Each task-specific exercise will be performed in 30-second "all out" bouts with a 1.5-minute rest after each bout.

FES+HIIT@Home

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be an adult (i.e., ≥18 years old) with a SCI at T12 or above as individuals with a lower motor neuron condition are considered poor candidates for FES.
  • Have a SCI rated as American Spinal Injury Association Impairment Scale A, B, C or D. If no recent (i.e., in past six months) AIS rating is available in the medical record, the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam (Rupp et al. 2021) will be completed by the research team.
  • Be \>1 year post-injury, in the case of traumatic SCI, or \>1 year post-onset of neurological symptoms, in the case of a non-progressive, non-traumatic cause of SCI.
  • Be able to attend 8 assessment sessions and three education sessions at the Lyndhurst Centre or Rumsey Cardiac Rehab, as well as 36 FES+HIIT@Home sessions and one education session on Microsoft Teams.
  • Be ambulatory or use a manual wheelchair.
  • Be able to don/doff electrodes independently or with support from a family member or other caregiver.
  • Have physician clearance to participate in high intensity interval training (i.e., no contraindications to HIIT).
  • Have an emergency contact who can be reached by the research team during FES+HIIT@Home sessions.
  • Able to understand spoken English.

You may not qualify if:

  • Presents with contraindications to FES (i.e. implanted electronic device, radiation in past six months, active deep vein thrombosis, pregnancy) (Houghton et al. 2010).
  • Presents with cognitive deficits that would prevent independent use of an FES device.
  • Has irritated and/or damaged skin in areas where the electrodes will be applied.
  • Has a cardiovascular morbidity that would limit exercise tolerance, as identified through pre-intervention cardiorespiratory fitness testing (e.g., complex arrhythmias).
  • Participant receives a Botox injection or begins a new therapy or exercise program during the first 20 weeks of the study (i.e., prior to the post-intervention assessments).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KITE Research Institute, Toronto Rehabilitation Institute-University Health Network

Toronto, Ontario, M4G 3V9, Canada

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Kristin E Musselman, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristin E Musselman, PhD

CONTACT

Katherine Chan, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 11, 2026

First Posted

August 19, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

The de-identified, quantitative datasets will be shared through the Open Data Commons for Spinal Cord Injury (odc-sci.org) and supplementary files will be made available in the publications.

Shared Documents
STUDY PROTOCOL

Locations